GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) analyst actions
Rating and price-target actions on GSK in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the GSK overview →
2 measured GSK analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GSK plc (GSK) And Encourages Shareholders to Reach Out | Press release | +0.22% | +1.51% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GSK plc (GSK) And Encourages Stockholders to Reach Out | Press release | +0.04% | +0.78% |
Keep exploring
More GSK: earnings → · SEC filings → · GSK overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Centene Corporation (CNC) | 1,456 | +0.01% | 50% |
| Fluidigm Corporation (FLDM) | 1,452 | 0.00% | 49% |
| GENMARK DIAGNOSTICS (GNMK) | 1,451 | +0.06% | 51% |
| Replimune Group, Inc. (REPL) | 1,432 | +0.09% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.